Morgan Stanley Neuro Pace Inc Put Options Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NPCE
# of Institutions
61Shares Held
18.7MCall Options Held
28.9KPut Options Held
7.5K-
Kck Ltd. Tortola, D85.62MShares$42.5 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA4MShares$30.3 Million1.19% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$18.4 Million2.63% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT778KShares$5.88 Million0.66% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA644KShares$4.87 Million4.05% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $188M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...